Disc Medicine (IRON) Non Operating Income (2021 - 2026)
Disc Medicine (IRON) reported Non Operating Income of $6.1 million for Q1 2026, up 1.52% year-over-year from $6.0 million in Q1 2025, and up 134.44% quarter-over-quarter from -$17.6 million in Q4 2025.
Disc Medicine (IRON) Non Operating Income (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Non Operating Income data on file, last reported at $6.1 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $6.1 million, up 1.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $136000.0 (down 98.71% YoY), and the FY2025 annual result was $45000.0, up 2350.0% from the prior year.
- Non Operating Income climbed to $6.1 million in Q1 2026 per IRON's latest filing, from -$17.6 million in the prior quarter.
- Over five years, Non Operating Income peaked at $6.2 million in Q2 2025 and troughed at -$17.6 million in Q4 2025.
- A 5-year average of $1.8 million and a median of $2.4 million in 2022 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 598100.0% in 2025 and fell as far as 587666.67% in 2025.
- A 5-year view of Non Operating Income shows it stood at $648000.0 in 2022, then soared by 851.7% to $6.2 million in 2023, then sank by 99.95% to $3000.0 in 2024, then tumbled by 587666.67% to -$17.6 million in 2025, then soared by 134.44% to $6.1 million in 2026.
- Business Quant data shows IRON's Non Operating Income at $6.1 million in Q1 2026, -$17.6 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | 6.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.07 Mn |
| Dec 31, 2025 | -17.63 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 5.98 Mn |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 6.17 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Dec 31, 2022 | 648,000.00 |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | -5.02 Mn |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -11,000.00 |